Cardiology

Wool heart
Biotech

Don't count out Alnylam's next-gen silencer in ATTR-CM: analysts

Patients' disease stage, transthyretin knockdown levels and trial design have become focal points in debates around silencer-stabilizer combos.
Half of brain next to half of heart

Rethinking heart attacks as the nervous system gone haywire

Jan 27, 2026 11:00am
Boston Scientific HQ

Acquisitive Boston Scientific sees growth rate ease in Q3

Oct 22, 2025 10:05am
Cardiomyopathy

Cell lines could lead to new drugs for deadly heart condition

Jun 4, 2024 2:12pm
photo of a royal flush laid out on the poker table with chips scattered nearby

Cytokinetics shows hand in high stakes rivalry with BMS' Camzyos

May 13, 2024 9:36am
heart disease AKG monitor flatline pulse AFIB

Imbria hits safety benchmark in phase 2 heart failure test

Nov 7, 2023 9:55am